135 related articles for article (PubMed ID: 9209520)
1. P-glycoprotein expression in cartilaginous tumors.
Rosier RN; O'Keefe RJ; Teot LA; Fox EJ; Nester TA; Puzas JE; Reynolds PR; Hicks DG
J Surg Oncol; 1997 Jun; 65(2):95-105. PubMed ID: 9209520
[TBL] [Abstract][Full Text] [Related]
2. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract][Full Text] [Related]
3. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
[TBL] [Abstract][Full Text] [Related]
4. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
Lee FY; Yu J; Chang SS; Fawwaz R; Parisien MV
J Bone Joint Surg Am; 2004 Dec; 86(12):2677-85. PubMed ID: 15590853
[TBL] [Abstract][Full Text] [Related]
6. The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas.
He L; Yang Z; Li Z
Pathol Res Pract; 2016 Jul; 212(7):636-42. PubMed ID: 27155928
[TBL] [Abstract][Full Text] [Related]
7. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
He L; Yang Z; Zhou J; Wang W
Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
[TBL] [Abstract][Full Text] [Related]
8. The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting.
Hameetman L; Kok P; Eilers PH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
Virchows Arch; 2005 Apr; 446(4):430-7. PubMed ID: 15744499
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
Bovée JV; van den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
Lab Invest; 2000 Dec; 80(12):1925-34. PubMed ID: 11140704
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic features of osteochondroma with malignant transformation].
Zheng L; Zhang HZ; Huang J; Tang J; Liu L; Jiang ZM
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):609-13. PubMed ID: 20079189
[TBL] [Abstract][Full Text] [Related]
11. Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients.
Altay M; Bayrakci K; Yildiz Y; Erekul S; Saglik Y
J Orthop Sci; 2007 Sep; 12(5):415-23. PubMed ID: 17909925
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy and P-glycoprotein expression in chondrosarcoma.
Terek RM; Schwartz GK; Devaney K; Glantz L; Mak S; Healey JH; Albino AP
J Orthop Res; 1998 Sep; 16(5):585-90. PubMed ID: 9820282
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
14. Detection of P-glycoprotein in frozen and paraffin-embedded gastric adenocarcinoma tissues using a panel of monoclonal antibodies.
Lacueva FJ; Teruel A; Calpena R; Medrano J; Mayol MJ; Perez-Vazquez MT; Rufete C; Camarasa MV; Ferragut JA
Histopathology; 1998 Apr; 32(4):328-34. PubMed ID: 9602329
[TBL] [Abstract][Full Text] [Related]
15. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
[TBL] [Abstract][Full Text] [Related]
16. Cartilage-forming tumors.
Qasem SA; DeYoung BR
Semin Diagn Pathol; 2014 Jan; 31(1):10-20. PubMed ID: 24680178
[TBL] [Abstract][Full Text] [Related]
17. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.
Bovée JV; Hogendoorn PC; Wunder JS; Alman BA
Nat Rev Cancer; 2010 Jul; 10(7):481-8. PubMed ID: 20535132
[TBL] [Abstract][Full Text] [Related]
18. Expression of connective tissue growth factor in cartilaginous tumors.
Shakunaga T; Ozaki T; Ohara N; Asaumi K; Doi T; Nishida K; Kawai A; Nakanishi T; Takigawa M; Inoue H
Cancer; 2000 Oct; 89(7):1466-73. PubMed ID: 11013359
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
20. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]